1: Keshishian A, Xie L, Dembek C, Yuce H. Reduction in Hospital Readmission Rates Among Medicare Beneficiaries With Chronic Obstructive Pulmonary Disease: A Real-world Outcomes Study of Nebulized Bronchodilators. Clin Ther. 2019 Nov;41(11):2283-2296. 

2: Mollard S, Lurienne L, Heimann SM, Bandinelli PA. Burden of Clostridium (Clostridioides) difficile infection during inpatient stays in the USA between 2012 and 2016. J Hosp Infect. 2019 Jun;102(2):135-140. 

3: Vallabhaneni S, Baggs J, Tsay S, Srinivasan AR, Jernigan JA, Jackson BR. Trends in antifungal use in US hospitals, 2006-12. J Antimicrob Chemother. 2018 Oct 1;73(10):2867-2875. 

4: Baggs J, Jernigan JA, Halpin AL, Epstein L, Hatfield KM, McDonald LC. Risk of Subsequent Sepsis Within 90 Days After a Hospital Stay by Type of Antibiotic Exposure. Clin Infect Dis. 2018 Mar 19;66(7):1004-1012.

5: Maiese BA, Pham AT, Shah MV, Eaddy MT, Lunacsek OE, Wan GJ. Hospitalization Costs for Patients Undergoing Orthopedic Surgery Treated With Intravenous Acetaminophen (IV-APAP) Plus Other IV Analgesics or IV Opioid Monotherapy for Postoperative Pain. Adv Ther. 2017 Feb;34(2):421-435. 

6: Margolis JM, Deitelzweig S, Kline J, Tran O, Smith DM, Crivera C, Bookhart B, Schein J. Pulmonary Embolism Inpatients Treated With Rivaroxaban Had Shorter Hospital Stays and Lower Costs Compared With Warfarin. Clin Ther. 2016 Nov;38(11):2496-2503. 

7: Baggs J, Fridkin SK, Pollack LA, Srinivasan A, Jernigan JA. Estimating National Trends in Inpatient Antibiotic Use Among US Hospitals From 2006 to 2012. JAMA Intern Med. 2016 Nov 1;176(11):1639-1648. 

8: Margolis JM, Deitelzweig S, Kline J, Tran O, Smith DM, Bookhart B, Crivera C, Schein J. Shorter Hospital Stays and Lower Costs for Rivaroxaban Compared With Warfarin for Venous Thrombosis Admissions. J Am Heart Assoc. 2016 Oct 6;5(10).

9: Yi SH, Jernigan JA, McDonald LC. Prevalence of probiotic use among inpatients: A descriptive study of 145 U.S. hospitals. Am J Infect Control. 2016 May 1;44(5):548-53. 

10: Montejano L, Vo L, McMorrow D. Transitions of Care for People with Type 2 Diabetes: Utilization of Antihyperglycemic Agents Pre- and Post-Hospitalization. Diabetes Ther. 2016 Mar;7(1):91-103. 

1. Khan BA, Singh T, Ng AL, Teo RZ. Health economics of kidney replacement therapy in Singapore: Taking stock and looking ahead. Annals of the Academy of Medicine, Singapore. 2022 Apr 1;51(4):236-40.

2. Khoo CY, Gao F, Choong HL, Tan WXA, Koniman R, Fam JM, Yeo KK. Death and cardiovascular outcomes in end-stage renal failure patients on different modalities of dialysis. Ann Acad Med Singap. 2022 Mar;51(3):136-142. 

3. Geng TT, Jafar TH, Neelakantan N, Yuan JM, van Dam RM, Koh WP. Healthful dietary patterns and risk of end-stage kidney disease: the Singapore Chinese Health Study. Am J Clin Nutr. 2020 Dec 31:nqaa348. 

4. Leo CCH, Chan GC. Global Perspectives in Dialysis: Singapore. Kidney360. 2020 Sep 18;1(11):1306-1309. 

5. Geng TT, Jafar TH, Yuan JM, Koh WP. The impact of diabetes on the association between alcohol intake and the risk of end-stage kidney disease in the Singapore Chinese Health Study. J Diabetes. 2020 Aug;12(8):583-593

6. Tan KW, Dickens BSL, Cook AR. Projected burden of type 2 diabetes mellitus-related complications in Singapore until 2050: a Bayesian evidence synthesis. BMJ Open Diabetes Res Care. 2020 Mar;8(1):e000928. 

7. Wang Y, Nguyen FNHL, Allen JC, Lew JQL, Tan NC, Jafar TH. Validation of the kidney failure risk equation for end-stage kidney disease in Southeast Asia. BMC Nephrol. 2019 Dec 4;20(1):451. 

8. Geng TT, Talaei M, Jafar TH, Yuan JM, Koh WP. Pulse Pressure and the Risk of End-Stage Renal Disease Among Chinese Adults in Singapore: The Singapore Chinese Health Study. J Am Heart Assoc. 2019 Dec 3;8(23):e013282. 

9. Lim CC, Chee ML, Cheng CY, Kwek JL, Foo M, Wong TY, Sabanayagam C. Simplified end stage renal failure risk prediction model for the low-risk general population with chronic kidney disease. PLoS One. 2019 Feb 22;14(2):e0212590. 

10. Geng TT, Jafar TH, Yuan JM, Koh WP. Sleep duration and risk of end-stage renal disease: the Singapore Chinese Health Study. Sleep Med. 2019 Feb;54:22-27.  

1. Sun S, Wang H. Clocking Epilepsies: A Chronomodulated Strategy-Based Therapy for Rhythmic Seizures. Int J Mol Sci. 2023 Feb 20;24(4):4223.

2. Liu X, Wang Y, Zhang Y, Jiang H, Huo X, Liu R. Integrated Bioinformatic Analysis and Experimental Validation to Reveal the Mechanisms of Xinfeng Capsule Against Rheumatoid Arthritis. Comb Chem High Throughput Screen. 2023 Jan 27. doi: 10.2174/1386207326666230127151049. Epub ahead of print. PMID: 36705239.

3. Yu W, Drzymalla E, Gwinn M, Khoury MJ. COVID-19 GPH: tracking the contribution of genomics and precision health to the COVID-19 pandemic response. BMC Infect Dis. 2022 Apr 25;22(1):402.

4. Khoury MJ, Armstrong GL, Bunnell RE, Cyril J, Iademarco MF. The intersection of genomics and big data with public health: Opportunities for precision public health. PLoS Medicine. 2020 Oct 29;17(10):e1003373.

5. Shen Y, Li M, Liu K, Xu X, Zhu S, Wang N, Guo W, Zhao Q, Lu P, Yu F, Xu X. Integrated bioinformatics analysis of aberrantly-methylated differentially-expressed genes and pathways in age-related macular degeneration. BMC Ophthalmol. 2020 Mar 24;20(1):119.

6. Yu W, Gwinn M, Khoury MJ. A New Resource for Genomics and Precision Health Information and Publications on the Investigation and Control of COVID-19 and other Coronaviruses. BioRxiv. 2020 Jan 1. [Unpublished pre-print]

7. Barbitoff YA, Tsarev AA, Vashukova ES, Maksiutenko EM, Kovalenko LV, Belotserkovtseva LD, Glotov AS. A data-driven review of the genetic factors of pregnancy complications. International journal of molecular sciences. 2020 Jan;21(9):3384.

8. Lee K, Clyne M, Yu W, Lu Z, Khoury MJ. Tracking human genes along the translational continuum. NPJ Genom Med. 2019 Oct 16;4:25.

9. Mensah GA, Yu W, Barfield WL, Clyne M, Engelgau MM, Khoury MJ. HLBS-PopOmics: an online knowledge base to accelerate dissemination and implementation of research advances in population genomics to reduce the burden of heart, lung, blood, and sleep disorders. Genetics in Medicine. 2019 Mar;21(3):519-24.

10. Yu W, Gwinn M, Dotson WD, Green RF, Clyne M, Wulf A, Bowen S, Kolor K, Khoury MJ. A knowledge base for tracking the impact of genomics on population health. Genet Med. 2016 Dec;18(12):1312-1314.